LevOmega
Advancing Omega Innovation Through Strategic Collaboration
LevOmega is a company co-founded by Levur, Green Blue Health, and LTR Pharma.
By combining scientific innovation, nutraceutical expertise, and pharmaceutical commercialisation, LevOmega is positioned to advance next-generation omega solutions for global markets.
Our Strength in Partnership
Together, these complementary strengths create a unique platform for delivering differentiated omega solutions.
Levur
Innovation and product development expertise
Green Blue Health
Nutraceutical and health market experience
LTR Pharma
Pharmaceutical, regulatory, and commercialisation capability
Our Strength in Partnership
Together, these complementary strengths create a unique platform for delivering differentiated omega solutions.
Market Opportunity
The global omega-3 market is large and growing rapidly. Estimates place the overall market at around USD 9.3 billion in 2025, with projections toward USD 17.9 billion by 2034 (≈7.5% CAGR). The supplements segment alone was already worth USD 8.4 billion in 2024, expected to nearly double in size over the next decade.
Despite this scale, there remain unmet needs in efficacy, consistency, delivery, and differentiation. LevOmega is built to address those gaps.
For media enquiries, please contact: